第4回 UTOPIAシンポジウム

*Toshifumi Inada¹ (1. Division of RNA and gene regulation The Institute of Medical Science, The University of Tokyo (Japan))

*Mutsuhiro Takekawa¹ (1. Division of Cell Signaling and Molecular Medicine, Institute of Medical Science, The University of Tokyo (Japan))

*Tomohisa Okamura¹, Hiroyuki Teruya², Manaka Goto¹, Keishi Fujio² (1. Department of Functional Genomics and Immunological Diseases, Graduate School of Medicine, The University of Tokyo (Japan), 2. Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo (Japan))

*Emi K. Nishimura¹ (1. Division of Aging and Rengeration, IMSUT (Japan))

*Kazuo Takayama^1,2 (1. Medical Research Laboratory, Institute of Integrated Research, Institute of Science Tokyo (Japan), 2. Department of State-of-the-art and International Medicine, Graduate School of Medicine, Kyoto University (Japan))

*Kotaro Kiga¹ (1. Department of Drug Development, National Institute of Infectious Diseases, Japan Institute for Health Security (Japan))

*Genta Nagao^1,2, Chifune Kai³, Takanori Asakura², Koichi Fukunaga², Ho Namkoong², Yukinori Okada^1,3,4 (1. The University of Tokyo (Japan), 2. Keio University (Japan), 3. The University of Osaka (Japan), 4. RIKEN Center (Japan))

*Takashi OKADA¹ (1. Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo (Japan))

*Sho Ohta¹, Yasuhiro Yamada¹ (1. Graduate School of Medicine, The University of Tokyo (Japan))